1. Home
  2. ONCY vs ACOG Comparison

ONCY vs ACOG Comparison

Compare ONCY & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.85

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.40

Market Cap

110.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONCY
ACOG
Founded
1998
2000
Country
Canada
Canada
Employees
N/A
57
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.0M
110.4M
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
ONCY
ACOG
Price
$0.85
$5.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$7.33
$18.00
AVG Volume (30 Days)
800.6K
40.2K
Earning Date
05-13-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$146.05
Revenue Next Year
N/A
$127.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$3.75
52 Week High
$1.51
$10.88

Technical Indicators

Market Signals
Indicator
ONCY
ACOG
Relative Strength Index (RSI) 38.32 44.18
Support Level $0.79 $5.16
Resistance Level $1.32 $6.52
Average True Range (ATR) 0.06 0.38
MACD -0.02 -0.06
Stochastic Oscillator 25.73 40.91

Price Performance

Historical Comparison
ONCY
ACOG

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: